Cancerous stem cells can arise from pediatric brain tumors

Pediatric brain tumors are significant causes of morbidity and mortality. It has been hypothesized that they derive from self-renewing multipotent neural stem cells. Here, we tested whether different pediatric brain tumors, including medulloblastomas and gliomas, contain cells with properties similar to neural stem cells. We find that tumor-derived progenitors form neurospheres that can be passaged at clonal density and are able to self-renew. Under conditions promoting differentiation, individual cells are multipotent, giving rise to both neurons and glia, in proportions that reflect the tumor of origin. Unlike normal neural stem cells, however, tumor-derived progenitors have an unusual capacity to proliferate and sometimes differentiate into abnormal cells with multiple differentiation markers. Gene expression analysis reveals that both whole tumors and tumor-derived neurospheres express many genes characteristic of neural and other stem cells, including CD133, Sox2, musashi-1, bmi-1, maternal embryonic leucine zipper kinase, and phosphoserine phosphatase, with variation from tumor to tumor. After grafting to neonatal rat brains, tumor-derived neurosphere cells migrate, produce neurons and glia, and continue to proliferate for more than 4 weeks. The results show that pediatric brain tumors contain neural stem-like cells with altered characteristics that may contribute to tumorigenesis. This finding may have important implications for treatment by means of specific targeting of stem-like cells within brain tumors.

[1]  R. McKay,et al.  The neuroepithelial stem cell concept: Implications for neuro-oncology , 2005, Journal of Neuro-Oncology.

[2]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[3]  L. Pevny,et al.  SOX2 Functions to Maintain Neural Progenitor Identity , 2003, Neuron.

[4]  G. Sauvageau,et al.  Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.

[5]  Irving L. Weissman,et al.  Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells , 2003, Nature.

[6]  Paul S Mischel,et al.  Identification of molecular subtypes of glioblastoma by gene expression profiling , 2003, Oncogene.

[7]  M. Santi,et al.  Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors. , 2003, The oncologist.

[8]  M. Sofroniew,et al.  The Predominant Neural Stem Cell Isolated from Postnatal and Adult Forebrain But Not Early Embryonic Forebrain Expresses GFAP , 2003, The Journal of Neuroscience.

[9]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Rao,et al.  Properties of a fetal multipotent neural stem cell (NEP cell). , 2002, Developmental biology.

[11]  H. Okano,et al.  RNA-binding protein Musashi family: Roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Steindler,et al.  Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro , 2002, Glia.

[13]  C. Sklar.  Childhood Brain Tumors , 2002, Journal of pediatric endocrinology & metabolism : JPEM.

[14]  G. Reifenberger,et al.  The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.

[15]  U. Lendahl,et al.  Immunohistochemical Detection of Nestin in Pediatric Brain Tumors , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  Arturo Alvarez-Buylla,et al.  Neurogenesis in Adult Subventricular Zone , 2002, The Journal of Neuroscience.

[17]  A. Trumpp,et al.  Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo , 2001, Science.

[18]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[19]  D. Geschwind,et al.  From hematopoiesis to neuropoiesis: Evidence of overlapping genetic programs , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Allibone,et al.  Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma , 2001, Genes, chromosomes & cancer.

[21]  J. Taipale,et al.  The Hedgehog and Wnt signalling pathways in cancer , 2001, Nature.

[22]  Irving L. Weissman,et al.  A Genetic Analysis of Neural Progenitor Differentiation , 2001, Neuron.

[23]  S. Morrison,et al.  Stem cell potential: Can anything make anything? , 2001, Current Biology.

[24]  M. Scott,et al.  The developmental biology of brain tumors. , 2001, Annual review of neuroscience.

[25]  I. Weissman,et al.  Direct isolation of human central nervous system stem cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Luskin,et al.  Region-specific differentiation of neural tube-derived neuronal restricted progenitor cells after heterotopic transplantation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Lovell-Badge,et al.  Sox2 regulatory sequences direct expression of a (beta)-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells. , 2000, Development.

[28]  Eric C. Holland,et al.  Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice , 2000, Nature Genetics.

[29]  H. Okano,et al.  Musashi1: An Evolutionally Conserved Marker for CNS Progenitor Cells Including Neural Stem Cells , 2000, Developmental Neuroscience.

[30]  E. Holland.  A Mouse Model for Glioma: Biology, Pathology, and Therapeutic Opportunities , 2000, Toxicologic pathology.

[31]  Clive N Svendsen,et al.  A new method for the rapid and long term growth of human neural precursor cells , 1998, Journal of Neuroscience Methods.

[32]  R. McKay,et al.  Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats , 1998, Nature Biotechnology.

[33]  B. Freidlin,et al.  Trends in reported incidence of primary malignant brain tumors in children in the United States. , 1998, Journal of the National Cancer Institute.

[34]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[35]  J. Trojanowski,et al.  Primitive Neuroectodermal Tumors of the Central Nervous System , 1997, Brain pathology.

[36]  A. Mccarthy.  Development , 1996, Current Opinion in Neurobiology.

[37]  C. Taylor,et al.  Comparison of two microwave based antigen-retrieval solutions in unmasking epitopes in formalin-fixed tissue for immunostaining. , 1995, Anticancer research.

[38]  Genes, chromosomes & cancer , 1995 .

[39]  P. Phillips,et al.  Midline supratentorial tumors. , 1992, Neurosurgery clinics of North America.

[40]  S. Weiss,et al.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.

[41]  J. Trojanowski,et al.  Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[42]  R. McKay,et al.  An embryonic origin for medulloblastoma. , 1991, The New biologist.

[43]  R. McKay,et al.  CNS stem cells express a new class of intermediate filament protein , 1990, Cell.

[44]  W. Koos,et al.  Statistics of intracranial midline tumors in children. , 1985, Acta neurochirurgica. Supplementum.

[45]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[46]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.